Literature DB >> 26979591

Reporting transparency: making the ethical mandate explicit.

Stuart G Nicholls1,2, Sinéad M Langan3, Eric I Benchimol4,5,6,7, David Moher5,8.   

Abstract

Improving the transparency and quality of reporting in biomedical research is considered ethically important; yet, this is often based on practical reasons such as the facilitation of peer review. Surprisingly, there has been little explicit discussion regarding the ethical obligations that underpin reporting guidelines. In this commentary, we suggest a number of ethical drivers for the improved reporting of research. These ethical drivers relate to researcher integrity as well as to the benefits derived from improved reporting such as the fair use of resources, minimizing risk of harms, and maximizing benefits. Despite their undoubted benefit to reporting completeness, questions remain regarding the extent to which reporting guidelines can influence processes beyond publication, including researcher integrity or the uptake of scientific research findings into policy or practice. Thus, we consider investigation on the effects of reporting guidelines an important step in providing evidence of their benefits.

Entities:  

Keywords:  Moral obligations; Publication bias; Research personnel/ethics; Research waste; Social values; Standards

Mesh:

Year:  2016        PMID: 26979591      PMCID: PMC4793699          DOI: 10.1186/s12916-016-0587-5

Source DB:  PubMed          Journal:  BMC Med        ISSN: 1741-7015            Impact factor:   8.775


Background

Poor research reporting has been estimated to lead to billions of dollars of waste due to unusable results [1]. Key codes of medical practice, such as the Declaration of Helsinki, state that researchers are accountable for the completeness and accuracy of their reports and that these should adhere to accepted guidelines for ethical reporting [2]. Nevertheless, despite such declarations, there has been little explication as to the principles guiding this ethical obligation. The present commentary addresses why researchers should improve their reporting practices, arguing that the important ethical drivers of these obligations are based on the integrity of individuals as researchers as well as the implications for research use, and concluding that reporting guidelines may help us meet these obligations. However, to date, evidence on the latter is lacking.

Researchers, research integrity, and trustworthiness

From an individual’s integrity perspective, obligations derive from values pertaining to those conducting and reporting research. The onus is placed on individuals being honest in their research, with evidence provided in the form of complete and accurate reporting [3]. Furthermore, the principles of fairness and reciprocity require researchers to contribute to the accumulating pool of scientific knowledge [4]. Appropriate contribution requires the content of publications to be useable. Improved reporting increases the potential for appropriate review and evaluation of research, allowing researchers to meet their obligations by usefully contributing to the collective knowledge upon which they draw. Improving reporting of research may also allow researchers to fulfil what Carter et al. [4] called the ‘social license’ of research, which requires researchers to go beyond mere compliance with legal mandates and act in accordance with the expectations of society regarding the conduct of research activities, the implication being that poorly reported research fails to meet the societal expectations required for the maintenance of such a license.

Extrinsic values and implications for research

Obligations regarding reporting also stem from principles external to the integrity of individual researchers and reflect concerns regarding the final use of data and results. These obligations include principles of avoiding harms and promoting benefits, and fair use of resources. If poor reporting is an impediment to appropriate implementation of research findings, then unwarranted or inappropriate use of research findings may expose patients to unnecessary risk of harm [5], while a failure to take up potentially beneficial research may lead to individual or population health benefits being missed [6]. This concept is important from a perspective of distributive justice, particularly if the failure to replicate research leads to an unwarranted burden on some members of society [7]. Being able to verify the veracity of the data and analysis will be essential in such circumstances. Moreover, there are opportunity costs to funding research. While clear reporting can facilitate replication and reproduction to validate findings, poorly reported research may precipitate a waste of resources if research funds are spent on unsuccessful attempts at reproduction that could have been circumvented had reporting been more complete. A number of studies have shown the difficulties in reproducing research findings [8, 9], with many citing poor reporting of methods for the inability to reproduce results.

Reporting guidelines and meeting the ethical mandate

Reporting guidelines serve as a tool in supporting best practice in reporting. Indeed, several studies have indicated that the use of checklists improves the completeness of reporting [10-14]. The utility of reporting guidelines lies in clear reporting standards that not only serve as an aid for content in reporting, but may also prompt prospective consideration of pertinent issues during the conception of research [15]. Developed through a profession- or topic-specific consensus approach, reporting guidelines represent a form of self-regulation, as they become a set of de facto standards or professional norms. Their self-regulatory component reflects on the community’s desire to be seen as open, transparent, and honest – derived from the individual motivators for openness – yet guidelines also serve the external drivers; they are often endorsed, or compliance mandated, by journals [16]. By improving knowledge transfer, reporting guidelines may facilitate trustworthiness in, and accountability of, individuals under what O’Neill refers to as the ‘openness agenda’ and the ‘audit agenda’ [17]. Under the openness agenda, study reports that are compliant with best practice are used as a marker of trustworthiness and reflect the honesty of the author(s) through their willingness to transparently report their research. Under the audit agenda, transparent reporting improves accountability by facilitating inspection of performance with respect to professional standards [18]. More complete reporting – consistent with appropriate reporting guidelines – also assists the conduct of systematic reviews and meta-analyses through the better documentation of elements that would require extraction [18, 19]. Such improved reporting may increase the appropriate uptake of research findings.

Conclusion

We have suggested that there are principled reasons behind the obligations to improve the reporting of research and note that this motivation reflects the integrity of individual researchers as well as the external drivers that pertain to the use of research results. While reporting guidelines serve as a tool for multiple stakeholders, including researchers, prospective authors, and peer reviewers, questions remain regarding the extent to which they can influence processes beyond publication: to what extent do they influence researcher integrity or the uptake of scientific research findings into policy or practice? Put differently, how do they address the ethical drivers that have stimulated the production of reporting guidelines? Evaluations of reporting guidelines have tended to focus on intermediary outcomes or the extent to which published studies comply with the elements within guidelines. Even then, there has been surprisingly limited work in terms of guideline evaluation [20]. Indeed, the direct beneficiaries of reporting guidelines are generally researchers and those who peer review research [18]. We believe that the paucity of research on the efficacy and effectiveness of reporting guidelines is due to the complex nature of these interactions. It is difficult to attribute the endpoints, such as use of research in policy, to the way the study was reported. However, we believe that demonstrating the effectiveness of reporting guidelines is an important step in providing evidence of their applied benefits to both research funders and the broader public, as researchers seek to justify their work in an era of increasing financial constraints. Hence, while improving the quality of reporting stems from important ethical drivers such as researcher integrity and the benefits derived from improved reporting, questions regarding the extent to which reporting guidelines can influence researcher integrity, or the uptake of scientific research findings into policy or practice, remain an important and under-investigated area for future research.
  16 in total

1.  Improving the reporting of public health intervention research: advancing TREND and CONSORT.

Authors:  Rebecca Armstrong; Elizabeth Waters; Laurence Moore; Elisha Riggs; Luis Gabriel Cuervo; Pisake Lumbiganon; Penelope Hawe
Journal:  J Public Health (Oxf)       Date:  2008-01-19       Impact factor: 2.341

2.  Improving the clarity and transparency of reporting health research: a shared obligation and responsibility.

Authors:  I Needleman; D Moher; D G Altman; K F Schulz; D R Moles; H Worthington
Journal:  J Dent Res       Date:  2008-10       Impact factor: 6.116

3.  Using the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement to assess reporting of observational trials in hand surgery.

Authors:  Amelia A Sorensen; Robert D Wojahn; Mary Claire Manske; Ryan P Calfee
Journal:  J Hand Surg Am       Date:  2013-07-08       Impact factor: 2.230

Review 4.  Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.

Authors:  Lucy Turner; Larissa Shamseer; Douglas G Altman; Laura Weeks; Jodi Peters; Thilo Kober; Sofia Dias; Kenneth F Schulz; Amy C Plint; David Moher
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

5.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

6.  Ethical aspects and dilemmas of preparing, writing and publishing of the scientific papers in the biomedical journals.

Authors:  Izet Masic
Journal:  Acta Inform Med       Date:  2012-09

7.  A systematic evaluation of the impact of STRICTA and CONSORT recommendations on quality of reporting for acupuncture trials.

Authors:  Stephanie L Prady; Stewart J Richmond; Veronica M Morton; Hugh Macpherson
Journal:  PLoS One       Date:  2008-02-13       Impact factor: 3.240

8.  Guidelines for reporting health research: the EQUATOR network's survey of guideline authors.

Authors:  Iveta Simera; Douglas G Altman; David Moher; Kenneth F Schulz; John Hoey
Journal:  PLoS Med       Date:  2008-06-24       Impact factor: 11.069

9.  On the reproducibility of science: unique identification of research resources in the biomedical literature.

Authors:  Nicole A Vasilevsky; Matthew H Brush; Holly Paddock; Laura Ponting; Shreejoy J Tripathy; Gregory M Larocca; Melissa A Haendel
Journal:  PeerJ       Date:  2013-09-05       Impact factor: 2.984

10.  Declaration of transparency for each research article.

Authors:  Douglas G Altman; David Moher
Journal:  BMJ       Date:  2013-08-07
View more
  10 in total

Review 1.  Enhancing primary reports of randomized controlled trials: Three most common challenges and suggested solutions.

Authors:  Guowei Li; Meha Bhatt; Mei Wang; Lawrence Mbuagbaw; Zainab Samaan; Lehana Thabane
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-12       Impact factor: 11.205

2.  Articulating 'free, prior and informed consent' (FPIC) for engineered gene drives.

Authors:  Dalton R George; Todd Kuiken; Jason A Delborne
Journal:  Proc Biol Sci       Date:  2019-12-18       Impact factor: 5.349

3. 

Authors:  Sinéad M Langan; Sigrún A J Schmidt; Kevin Wing; Vera Ehrenstein; Stuart G Nicholls; Kristian B Filion; Olaf Klungel; Irene Petersen; Henrik T Sørensen; William G Dixon; Astrid Guttmann; Katie Harron; Lars G Hemkens; David Moher; Sebastian Schneeweiss; Liam Smeeth; Miriam Sturkenboom; Erik von Elm; Shirley V Wang; Eric I Benchimol
Journal:  CMAJ       Date:  2019-06-24       Impact factor: 8.262

Review 4.  Sex-Divergent Clinical Outcomes and Precision Medicine: An Important New Role for Institutional Review Boards and Research Ethics Committees.

Authors:  Ignacio Segarra; Pilar Modamio; Cecilia Fernández; Eduardo L Mariño
Journal:  Front Pharmacol       Date:  2017-07-21       Impact factor: 5.810

5.  The file drawer effect: A call for meticulous methodology and tolerance for non-significant results.

Authors:  Priscilla Joys Nagarajan; Bharath Kumar Garla; M Taranath; I Nagarajan
Journal:  Indian J Anaesth       Date:  2017-06

6.  The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE).

Authors:  Sinéad M Langan; Sigrún Aj Schmidt; Kevin Wing; Vera Ehrenstein; Stuart G Nicholls; Kristian B Filion; Olaf Klungel; Irene Petersen; Henrik T Sorensen; William G Dixon; Astrid Guttmann; Katie Harron; Lars G Hemkens; David Moher; Sebastian Schneeweiss; Liam Smeeth; Miriam Sturkenboom; Erik von Elm; Shirley V Wang; Eric I Benchimol
Journal:  BMJ       Date:  2018-11-14

Review 7.  Reporting guidelines should be free to publish, read, and use.

Authors:  Patricia Logullo; Jennifer A de Beyer; Shona Kirtley; Caroline Struthers; Gary S Collins
Journal:  J Glob Health       Date:  2020-12       Impact factor: 4.413

Review 8.  Paper 4: a review of reporting and disseminating approaches for rapid reviews in health policy and systems research.

Authors:  Shannon E Kelly; Jessie McGowan; Kim Barnhardt; Sharon E Straus
Journal:  Syst Rev       Date:  2022-07-30

9.  Is there an agreement between self-reported medical diagnosis in the CARTaGENE cohort and the Québec administrative health databases?

Authors:  Y Payette; C S de Moura; C Boileau; S Bernatsky; N Noisel
Journal:  Int J Popul Data Sci       Date:  2020-03-26

10.  A Call to Accountability: Reporting Outcomes in Vascularized Composite Allotransplantation.

Authors:  James L Benedict; Nicholas L Robbins; Bruce Kaplan; Warren C Breidenbach
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-06-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.